References
- FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
- LiuZCaiWHeLIn vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in miceNat Nanotechnol200721475218654207
- LiLYWartchowCADanthiSNA novel antiangiogenesis therapy using an integrin antagonist or anti-FLK-1 antibody coated Y-90-labeled nanoparticlesInt J Radiat Oncol200458412151227
- WernerMEKarveSSukumarRFolate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasisBiomaterials201132338548855421843904
- TaiWYMahatoRChengKThe role of HER2 in cancer therapy and targeted drug deliveryJ Control Release2010146326427520385184
- DaiSRaviPTamKCThermo- and photo-responsive polymeric systemsSoft Matter200951325132533
- ChenBChengJWuYReversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-miceInt J Nanomedicine20094737819421372
- KonnoTHasudaHIshiharaKItoYPhoto-immobilization of a phospholipid polymer for surface modificationBiomaterials200526121381138815482825
- DanhierFFeronOPreatVTo exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug deliveryJ Control Release2010148213514620797419
- SteegPSTheodorescuDMetastasis: a therapeutic target for cancerNature Clinical Practice Oncology200854206219
- LawBTungCHProteolysis: A biological process adapted in drug delivery, therapy, and imagingBioconjugate Chem200920916831695
- ZhuLXieJSwierczewskaMReal-time video imaging of protease expression in vivoTheranostics20111182721461134
- DavidsenJVermehrenCFrokjaerSMouritsenOGJorgensenKDrug delivery by phospholipase A(2) degradable liposomesInt J Pharm20012141–2676911282239
- AimettiAATibbittMWAnsethKSHuman neutrophil elastase responsive delivery from poly(ethylene glycol) hydrogelsBiomacromolecules20091061484148919408953
- KessenbrockKPlaksVWerbZMatrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell20101411526720371345
- Lopez-OtinCMatrisianLMTumour micro environment-opinion-emerging roles of proteases in tumour suppressionNat Rev Cancer200771080080817851543
- GuptaGPMassagueJCancer metastasis: building a frameworkCell2006127467969517110329
- RoyRYangJMosesMAMatrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancerJ Clin Oncol200927315287529719738110
- AlbrightCFGracianiNHanWMatrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicityMol Cancer Ther20054575176015897239
- TeradaTIwaiMKawakamiSNovel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targetingJ Control Release2006111333334216488046
- ElegbedeAIBanerjeeJHansonAJMechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9J Am Chem Soc200813032106331064218642903
- LiRTLiXLXieLPreparation and evaluation of PEG-PCL nanoparticles for local tetradrine deliveryInt J Pharm2009379115816619524653
- ZhuZSLiYLiXLPaclitaxel-loaded poly(N-vinylpyrrolidone)- b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivoJ Control Release2010142343844619896997
- ChoYWLeeJLeeSCHuhKMParkKHydrotropic agents for study of in vitro paclitaxel release from polymeric micellesJ Control Release200497224925715196752
- HuYXieJTongYWWangCHEffect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cellsJ Control Release2007118171717241684
- FingletonBMMPs as therapeutic targets - Still a viable option?Semin Cell Dev Biol2008191616817693104
- OverallCMKleifeldOTowards third generation matrix metalloproteinase inhibitors for cancer therapyBrit J Cancer200694794194616538215
- JoralemonMJMcraeSEmrickTPEGylated polymers for medicine: from conjugation to self-assembled systemsChem Commun201046913771393
- WuWLiRTBianXCCovalently combining carbon nanotubes with anticancer agent: preparation and antitumor activityAcs Nano2009392740275019702292
- KarakotiASDasSThevuthasanSSealSPEGylated inorganic nanoparticlesAngew Chem Int Edit201150919801994
- WalkerGFFellaCPelisekJToward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivoMol Ther200511341842515727938
- LeeSRyuJHParkKPolymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivoNano Lett20099124412441619842672
- TurkBEHuangLLPiroETCantleyLCDetermination of protease cleavage site motifs using mixture-based oriented peptide librariesNat Biotechnol200119766166711433279
- HatakeyamaHItoEAkitaHA pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivoJ Control Release2009139212713219540888
- HatakeyamaHAkitaHKogureKDevelopment of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipidGene Ther2007141687716915290
- PetrosRADesimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
- RuoslahtiEBhatiaSNSailorMJTargeting of drugs and nanoparticles to tumorsJ Cell Biol2010188675976820231381
- NaganoSPerentesJYJainRKBoucherYCancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumorsCancer Res200868103795380218483263
- GoodmanTTOlivePLPunSHIncreased nanoparticle penetration in collagenase-treated multicellular spheroidsInt J Nanomedicine20072226527417722554
- MizushimaTIshiharaTTakedaMAccelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticlesPharmaceut Res2009261022702279
- ParkKTo PEGylate or not to PEGylate, that is not the questionJ Control Release2010142214714820096317
- ChenDLiuWShenYMuHZhangYLiangREffects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenonInt J Nanomedicine201162053206121976980
- XuHWangKQChenDWDengYHEffects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomesBiomaterials201031174757476320303164